دورية أكاديمية

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

التفاصيل البيبلوغرافية
العنوان: Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
المؤلفون: Khurana, Sandhya, Brusselle, Guy G., Bel, Elisabeth H., FitzGerald, J. Mark, Masoli, Matthew, Korn, Stephanie, Kato, Motokazu, Albers, Frank C., Bradford, Eric S., Gilson, Martyn J., Price, Robert G., Humbert, Marc
المصدر: In Clinical Therapeutics October 2019 41(10):2041-2056
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01492918
DOI:10.1016/j.clinthera.2019.07.007